Medtronic Minimally Invasive Therapies
Last update: November 4, 2020
Medical Equipment
United States (USA)
Its 6 main executivesRecent executive movements at Medtronic
Michael Coyle, Executive Vice President and Group President, Cardiac and Vascular Group, will leave the company on Dec. 31, 2020 (news posted on December 15 2020).
Sean Salmon who is Executive Vice President and Group President of Medtronic Diabetes, will become Executive Vice President and President, Cardiovascular on Jan. 1, 2021 (news posted on December 15 2020).
Geoffrey Martha who is Chief Executive Officer, will become Chief Executive Officer and Chairman of the Board on Dec. 11, 2020 (news posted on October 7 2020).
Click here to view some more movements at Medtronic
Create an alert
to follow the executive moves at Medtronic Minimally Invasive Therapies.
Most searched biographies at Medtronic Minimally Invasive Therapies
- Bob White, Executive Vice President and President
- David Carr, Vice President, EMEA
- John de Csepel, Chief Medical Officer and Vice President, Medical ...
Click on an executive to view his biography >
Latest M&A news in Medical Equipment.
Steris has announced the acquisition of Cantel Medical (posted on Jan 12, 2021).
Philips has announced the acquisition of BioTelemetry (posted on Dec 21, 2020).
Medtronic has acquired Medicrea (posted on Nov 18, 2020).
Other contacts in the Medical Equipment industry
Latest news about Medtronic Minimally Invasive Therapies
Medtronic Minimally Invasive Therapies on Wikipedia, Google News & Yahoo Finance
Medtronic Minimally Invasive Therapies on LinkedIn, Twitter & YouTube
Medtronic Minimally Invasive Therapies has 953 competitors including Philips (Netherlands), Thermo Fisher Scientific (United States (USA)) and BD (United States (USA)). Medtronic Minimally Invasive Therapies is owned by Medtronic.
Contact by email its executives including Bob White 
Call Medtronic Minimally Invasive Therapies at +1 763....
